Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A com...
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
About this item
Full title
Author / Creator
Puig, N , Sarasquete, M E , Balanzategui, A , Martínez, J , Paiva, B , García, H , Fumero, S , Jiménez, C , Alcoceba, M , Chillón, M C , Sebastián, E , Marín, L , Montalbán, M A , Mateos, M V , Oriol, A , Palomera, L , de la Rubia, J , Vidriales, M B , Bladé, J , Lahuerta, J J , González, M , Miguel, J F S and García-Sanz, R
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
We have analyzed the applicability, sensitivity and prognostic value of allele-specific oligonucleotide real-time quantitative PCR (ASO RQ-PCR) as a method for minimal residual disease (MRD) assessment in patients with multiple myeloma (MM), comparing the results with those of multiparameter flow cytometry (MFC). A total of 170 patients enrolled in...
Alternative Titles
Full title
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1524397640
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1524397640
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2013.217
